| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 04/08/2009 | CN101401799A Method for preparing farina microcapsule medicament |
| 04/08/2009 | CN101401798A Proanthocyanidin effervescent tablet and preparation method thereof |
| 04/08/2009 | CN101401793A Capsule type inhalation dust cloud agent |
| 04/08/2009 | CN100475881C Process for manufacturing polymers |
| 04/08/2009 | CN100475843C Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 04/08/2009 | CN100475837C Branched polyglycol-amino acid oligopeptide and active derivative and medicinal composition thereof |
| 04/08/2009 | CN100475776C Amino acid diamides in non alpha position useful as adjuvants for the administration of active biological agents |
| 04/08/2009 | CN100475707C Method for preparing magnetic Nano composite granules coated by cationic polyelectrolyte |
| 04/08/2009 | CN100475272C Stabiliser for radiopharmaceuticals |
| 04/08/2009 | CN100475270C Medicine for treating tumor, and application thereof |
| 04/08/2009 | CN100475269C Binding agent of hydrophilic polymer-glutamic acid oligopeptide and medicinal molecular, composition containing said binding agent and use thereof |
| 04/08/2009 | CN100475268C Recombinant adenovirus lyophilized preparation and preparing method thereof |
| 04/08/2009 | CN100475267C Liquid formulations with a high concentration of human growth hormone (hgh) comprising glycin |
| 04/08/2009 | CN100475266C Development of oviparous species by in ovo feeding |
| 04/08/2009 | CN100475222C Beewax essence millimicrosphere preparation and uses in medicine |
| 04/08/2009 | CN100475215C Cefuroxime axetil taste masking pellet and method of preparing the same |
| 04/08/2009 | CN100475213C Composition of an external dermatological agent and fibers with effect of promoting lipid decomposition |
| 04/08/2009 | CN100475204C Pilocarpine nitrate dispersible tablet and preparation method thereof |
| 04/08/2009 | CN100475203C Preparing method of triptolide molecule microcapsule |
| 04/08/2009 | CN100475201C Preparing method of slow released diacetyl rheinic acid tablet |
| 04/08/2009 | CN100475198C Biliquid foams, stable dispersions thereof and a corresponding process of manufacturing |
| 04/08/2009 | CN100475193C Nano-sized self-assembled structured liquid |
| 04/08/2009 | CN100475192C Ophthalmic compositions containing a synergistic combination of two polymers |
| 04/08/2009 | CN100475190C Implantation slow release medicine in eyes |
| 04/08/2009 | CN100475182C Composition for preventive treatment of herpessimplex |
| 04/07/2009 | US7514574 Biodegradable penetration enhancers with multiple hydrophilic moieties |
| 04/07/2009 | US7514552 cellulose hydrolyzates having an average polymerization degree of 150 to 450, microstructure particle sizes, an apparent specific volume of more than 7 cm3/g and a retention capacity for polyethylene glycol, useful as an excipient for medicines, foods or chemicals |
| 04/07/2009 | US7514543 Immunoglobulin fusion for use as therapeutic tool in prevention and treatment of chronic progression of atherosclerosis in diabetic patients |
| 04/07/2009 | US7514541 crosslinking with curing agents in acidic or alkaline conditions, to form to products used in cosmetic, medical and pharmaceutical applications |
| 04/07/2009 | US7514530 Peptide carrier for delivering siRNA into mammalian cells |
| 04/07/2009 | US7514472 Fat or oil composition |
| 04/07/2009 | US7514399 Use in tissue bonding and protein cross-linking and use in tissue and arterial repair, preservation of expanded internal luminal diameters, and local delivery of drugs, skin care materials, sunscreens, and cosmetics |
| 04/07/2009 | US7514105 Bioavailability/bioefficacy enhancing activity of Cuminum cyminum and extracts and fractions thereof |
| 04/07/2009 | US7514098 Use of targeted cross-linked nanoparticles for in vivo gene delivery |
| 04/07/2009 | US7514096 Triacylglycerols of enriched CLA content |
| 04/07/2009 | US7514095 Three-dimensional chitosan matrix or drug release; tissue engineering ; water in oil emulsion containing active materials; extrusion; coagulation |
| 04/07/2009 | US7514080 Drug conjugate composition |
| 04/07/2009 | US7514078 Methods of treating prostate cancer with anti-prostate specific membrane antigen antibodies |
| 04/07/2009 | US7514076 administering a D-amino acid oxidase which is chemically conjugated with a polymer, for accumulation in the tumor tissue, then administering D-amino acid which is a substrate for the D-amino acid oxidase, which releases reactive oxygen species; improved tumor selective cytotoxic activity results |
| 04/07/2009 | US7514067 Complexing enzyme with antibody; trapping within tumor |
| 04/07/2009 | US7514066 Targeted combination immunotherapy of cancer and infectious diseases |
| 04/07/2009 | CA2527366C A method of promoting sleep using topical administration of vasoactive agents |
| 04/07/2009 | CA2502103C Colon cleansing compositions |
| 04/07/2009 | CA2457564C Particle immobilized coatings and uses thereof |
| 04/07/2009 | CA2437743C Multifunctional particulate additive for personal care and cosmetic compositions, and the process of making the same |
| 04/07/2009 | CA2423574C Stabilization of solid drug formulations |
| 04/07/2009 | CA2410065C Micellar pharmaceutical compositions for buccal and pulmonary application |
| 04/07/2009 | CA2372384C Anti-inflammatory bioactive glass particulates |
| 04/07/2009 | CA2320072C Erythropoietin liposomal dispersion |
| 04/07/2009 | CA2313704C Recombinant nodavirus compositions and methods |
| 04/07/2009 | CA2312767C Drug delivery system with two-step targeting |
| 04/07/2009 | CA2281133C Multiple-agents-binding compound and use thereof |
| 04/07/2009 | CA2269060C Non-antigenic toxin-conjugate and fusion protein of internalizing receptor system |
| 04/07/2009 | CA2257378C Enteric coating, comprising alginic acid, for an oral preparation |
| 04/07/2009 | CA2192659C Adjuvant compositions comprising a mineral salt and another immunostimulating compound |
| 04/07/2009 | CA2176716C Preparation of biodegradable microparticles containing a biologically active agent |
| 04/02/2009 | WO2009043049A2 Pharmaceutical formulations |
| 04/02/2009 | WO2009043031A2 Microbubbles and methods for oxygen delivery |
| 04/02/2009 | WO2009042962A2 Antidotes for factor xa inhibitors and methods of using the same |
| 04/02/2009 | WO2009042922A2 Peptide-peptidase inhibitor conjugates and methods of making and using same |
| 04/02/2009 | WO2009042064A2 Oligomer-nucleoside phosphate conjugates |
| 04/02/2009 | WO2009041714A1 External preparation for free radical diseases |
| 04/02/2009 | WO2009041699A1 Bofutsushosan-containing preparation |
| 04/02/2009 | WO2009041698A1 Bofutsushosan-containing preparation |
| 04/02/2009 | WO2009041666A1 Cyclodextrin compound modified with folic acid, process for production thereof, drug delivery agent for targeting drug delivery system, pharmaceutical composition, and imaging agent |
| 04/02/2009 | WO2009041651A1 Rapidly disintegrating solid preparation |
| 04/02/2009 | WO2009041570A1 Polymer conjugate of steroid |
| 04/02/2009 | WO2009041549A1 Ophthalmic composition |
| 04/02/2009 | WO2009041122A1 Patch material |
| 04/02/2009 | WO2009041121A1 Cosmetic auxiliary patch material and method of cosmetizing therewith |
| 04/02/2009 | WO2009041111A1 Medicinal preparation for oral administration |
| 04/02/2009 | WO2009041105A1 Liquid composition for soft-capsule filling |
| 04/02/2009 | WO2009041037A1 Drug for suppressing pathogen occurring in vivo |
| 04/02/2009 | WO2009040843A2 Preparation of micro or nano systems detectable in biological environments based on inorganic oxides with controlled porosity for carrying biologically active or activable substances |
| 04/02/2009 | WO2009040811A2 Polymer nanoparticles coated by magnetic metal oxide and uses thereof |
| 04/02/2009 | WO2009040776A1 Self-emulsifying pharmaceutical compositions of rhein or diacerein |
| 04/02/2009 | WO2009040750A1 Composition and method of stabilized sensitive ingredient |
| 04/02/2009 | WO2009040363A1 Glycoproteins and glycosylated cells and a method for the preparation of the same |
| 04/02/2009 | WO2009039716A1 Carotenoid formulations and use thereof, and feeds containing the formulation and processes for the preparation of the feeds |
| 04/02/2009 | WO2009039628A1 Use of liposomes in a carrier comprising a continuous hydrophobic phase for delivery of polynucleotides in vivo |
| 04/02/2009 | WO2009039626A1 Enhanced drug delivery with orientable particles |
| 04/02/2009 | WO2009020314A3 Stabilized alpha-lipoic acid particles, composition comprising the same and method for preparing the same |
| 04/02/2009 | WO2008139313A3 Propofol transparent anaesthetic solution with low venous irritation |
| 04/02/2009 | WO2008036595A3 Subunguicide, and method for treating onychomycosis |
| 04/02/2009 | WO2008000517A3 Conjugates for innate immunotherapy of cancer |
| 04/02/2009 | WO2004110358A3 Polymeric conjugates for tissue activated drug delivery |
| 04/02/2009 | US20090088484 Nitric oxide (no)-releasing polymers and compounds and uses thereof |
| 04/02/2009 | US20090088464 Merged ion channel modulating compounds and Uses Thereof |
| 04/02/2009 | US20090088423 Methods and compositions for treating bacterial infections and diseases associated therewith |
| 04/02/2009 | US20090088408 Pharmaceutical compositions on anticholinergics, corticosteroids and betamimetics |
| 04/02/2009 | US20090087641 Porous nanosheath networks, method of making and uses thereof |
| 04/02/2009 | US20090087490 Extended release formulation and method of treating adrenergic dysregulation |
| 04/02/2009 | US20090087484 Formulation and dosage form for increasing oral bioavailability of hydrophilic macromolecules |
| 04/02/2009 | US20090087483 Oral dosage combination pharmaceutical packaging |
| 04/02/2009 | US20090087482 Temperature-Sensitive Liposomal Formulation |
| 04/02/2009 | US20090087477 Methods for preparing reverse micelles based on sterols and acylglycerols for the delivery of metal ions |
| 04/02/2009 | US20090087460 Solid composition, microparticles, microparticle dispersion liquid, and manufacturing methods for these |
| 04/02/2009 | US20090087440 Methods for Treating Cancer |
| 04/02/2009 | US20090087432 TREATING PROSTATE CANCER WITH ANTI-ErbB2 ANTIBODIES |
| 04/02/2009 | US20090087429 IL-17 homologous polypeptides and therapeutic uses thereof |